The approval, for patients with MASH with moderate to advanced liver scarring, was based on results of the Phase III MAESTRO-NASH trial, where the MASH resolved in 25.9% of patients who received an 80-mg dose of Rezdiffra and 29.9% of those taking 100 mg, with no worsening of fibrosis
Youve always prided yourself on doing whats best for your health but thought that aging was just a part of life. However, our research indicates that targeted interventions can delay the onset of age-related degeneration for years
Since millions of cells have to be replaced every minute, this is of paramount importance
Starting Doses Conservative protocols begin at 0.2-0.25 mg daily, allowing assessment of individual response before increasing dose
If youre ready to feel brighter, stronger and more energised, book your B12 booster appointment today and rediscover your best self